FDA Adverse Event Malfunction Summary report: N

COBAS 8000 C 702 MODULE

MDR report key: 17617610 · Received August 24, 2023

Report

Report Number
1823260-2023-02765
Event Type
Malfunction
Date Received
August 24, 2023
Date of Event
June 26, 2023
Report Date
August 24, 2023
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
UDI-DI
04015630930845
PMA / PMN Number
K100853
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PO
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE CREJ AND PHO REAGENTS' LOT NUMBERS AND EXPIRATION DATES WERE NOT PROVIDED. THE FIELD SERVICE ENGINEER (FSE) REPLACED THE DEGASSER, THE CUVETTES, THE HEAT CUT FILTER AND THE LAMP. HE ALSO WASHED THE CUVETTES, DID MEASUREMENT OF THE BLANK CELL AND ADJUSTED THE GEAR PUMP. CALIBRATION AND QC WERE PERFORMED AND THEY WERE ACCEPTABLE. PERFORMANCE CHECK WAS DONE AND THE INSTRUMENT WAS PERFORMING WITHIN SPECIFICATIONS. THE INVESTIGATION DETERMINED THAT THE ROOT CAUSE OF THE EVENT WAS CONSISTENT WITH A MAINTENANCE ISSUE. THE SERVICE ACTIONS (MAINTENANCE ACTIVITIES) RESOLVED THE ISSUE.

Description of Event or Problem · 0

WE RECEIVED AN ALLEGATION ABOUT DISCREPANT RESULTS FOR 2 PATIENTS' SAMPLES TESTED WITH CREATININE (CREJ) ASSAY AND 1 PATIENT'S SAMPLE TESTED WITH PHOSPHOROUS (PHO) ASSAY ON A COBAS 8000 C702 ANALYZER. SAMPLE 1: INITIAL CREJ RESULT: 1.24 MG/DL REPEAT CREJ RESULT: 3.98 MG/DL. SAMPLE 2: INITIAL CREJ RESULT: 1.44 MG/DL REPEAT CREJ RESULT: 4.03 MG/DL. SAMPLE 3: INITIAL PHO RESULT: 0.8 MG/DL REPEAT PHO RESULT: 2.0 MG/DL. IT IS UNKNOWN AT THIS POINT IF THE QUESTIONABLE RESULTS WERE REPORTED OUTSIDE THE LABORATORY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1167366 COBAS 8000 C 702 MODULE CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS 04015630930845

Patients

Seq Age Sex Outcome Treatment
1 Unknown